5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 13.53▼ | 13.53▼ | 13.53▼ | 13.50▼ | 13.16▲ |
MA10 | 13.38▲ | 13.32▲ | 13.32▲ | 13.29▲ | 13.47▲ |
MA20 | 13.41▲ | 13.43▲ | 13.49▼ | 13.09▲ | 13.36▲ |
MA50 | 13.56▼ | 13.39▲ | 13.36▲ | 13.51▼ | 13.77▼ |
MA100 | 13.49▼ | 13.65▼ | 13.72▼ | 13.45▲ | 13.46▲ |
MA200 | 13.79▼ | 13.78▼ | 13.76▼ | 13.81▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.037▲ | 0.029▲ | 0.015▲ | 0.090▲ | -0.011▼ |
RSI | 50.909▲ | 51.187▲ | 50.441▲ | 54.205▲ | 49.301▼ |
STOCH | 86.232▲ | 81.892▲ | 78.310 | 96.242▲ | 47.163 |
WILL %R | -31.405 | -31.405 | -31.405 | -11.040▲ | -26.963 |
CCI | 44.787 | 37.057 | 25.812 | 86.033 | 1.406 |
Tuesday, April 08, 2025 04:12 AM
The Nasdaq Composite (NASDAQINDEX: ^IXIC) is officially in a bear market. While it had been floating around in correction territory for a few weeks, it fell more than 20% below its all-time high ...
|
Monday, March 31, 2025 05:00 AM
March 31, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage ... target the urokinase plasminogen activator receptor (“uPAR”), which is expressed in numerous ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 13.574 | 13.574 | 13.4808 | 13.4808 | 1,148 |
30/04/25 | 13.48 | 13.545 | 13.48 | 13.545 | 6,200 |
29/04/25 | 13.60 | 13.605 | 13.60 | 13.605 | 21,201 |
28/04/25 | 13.43 | 13.47 | 13.43 | 13.465 | 5,700 |
25/04/25 | 13.425 | 13.425 | 13.425 | 13.425 | 49 |
24/04/25 | 13.15 | 13.41 | 13.15 | 13.41 | 19,100 |
23/04/25 | 13.31 | 13.31 | 13.147 | 13.147 | 800 |
22/04/25 | 12.92 | 13.055 | 12.92 | 13.05 | 13,507 |
21/04/25 | 12.95 | 12.95 | 12.7617 | 12.8007 | 9,383 |
17/04/25 | 12.98 | 13.005 | 12.98 | 13.005 | 900 |
|
|
||||
|
|
||||
|
|